Diagnostic’s World News’ Deborah Borfitz has published an interesting review of Ativa’s disruptive technologies and interview with CEO and Founder David Deetz. Read the full article here: https://www.diagnosticsworldnews.com/news/2019/10/08/ai-driven-diagnostic-hub-reimagines-primary-care
Ativa is honored to be working with Associate Professor James Fackler on developing and validating machine learning applications for critical care using digital blood samples from Ativa’s Diagnostic Workstation. Dr Fackler is a valued member of the Clinical Advisory Board…
David Deetz, Ativa founder and chief executive officer, created a buzz at the Next Generation Summit in Washington D.C. On August 21, David moderated a keynote panel discussion about what makes emerging technology attractive. He explained how a new approach…
For the inaugural year of AACC’s Disruptive Technology Award, the association accepted submissions from diagnostic developers of any size with products ranging from the early to late stages of development. From among these applicants 3 FINALISTS including Ativa will present data on…